Biohaven Pharmaceutical Holding Company Ltd. logo
Biohaven Pharmaceutical Holding Company Ltd. BHVN
$ 12.36 -9.65%
report update icon

Quarterly report 2022-Q2
added 06-06-2026

Biohaven Pharmaceutical Holding Company Ltd. Total Non Current Liabilities | BHVN

Annual Total Non Current Liabilities Biohaven Pharmaceutical Holding Company Ltd.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 802 M 286 M 120 M 5.49 M 1.9 M 476 K - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
802 M 476 K 203 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Non Current Liabilities Price % 24h Market Cap Country
Annexon Annexon
ANNX
23.3 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
612 K - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
27.9 M - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
17.8 M - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
2 K - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
2.03 M - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
44 K $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
11.2 M $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
5.12 M - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
6 M - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
35.2 M - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
615 K - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
10.9 M - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
806 M - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
743 M - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
1.93 M - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
127 M - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
36 M - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
227 M - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
12.6 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
272 K - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
18.7 M - - $ 109 M usaUSA
Akouos Akouos
AKUS
12 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
234 M - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
477 K - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
1.93 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
15 M - - $ 591 K irlandaIrlanda
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
996 K - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
25.2 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
9.13 M - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
78.7 M - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
79.1 M - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
170 M - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
276 K - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
12.3 M - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
9.41 M - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
31.9 M - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
274 K - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
9.97 M - - $ 127 M usaUSA
Aravive Aravive
ARAV
10.2 M - -13.39 % $ 1.45 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
4.9 M $ 84.95 0.13 % $ 7.99 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
244 K - 2.71 % $ 14 M usaUSA
Gilead Sciences Gilead Sciences
GILD
29.2 B $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
2.06 M $ 22.14 -1.6 % $ 248 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
218 M - - $ 2.02 B usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
2.42 M - -0.13 % $ 3.73 B usaUSA
Orgenesis Orgenesis
ORGS
12 M - -33.86 % $ 61.2 M usaUSA
TCR2 Therapeutics TCR2 Therapeutics
TCRR
807 K - - $ 58.1 M usaUSA